TORONTO, May 26, 2016 /CNW/ - Dr. Sven Rohmann, CEO and President, Helix BioPharma Corp. (HBP), joined Richard Rohan, VP, Corporate Sales, TMX Equity Transfer & Trust Company, to open the market to celebrate 20 years listed on Toronto Stock Exchange. Helix BioPharma Corp. is a biopharmaceutical company specializing in the development and commercialization of medicines in the areas of cancer prevention and treatment. Helix BioPharma Corp. commenced trading on Toronto Stock Exchange on June 3, 1996.

SOURCE TMX Group Limited

Copyright 2016 Canada NewsWire

Helix BioPharma (TSX:HBP)
過去 株価チャート
から 5 2024 まで 6 2024 Helix BioPharmaのチャートをもっと見るにはこちらをクリック
Helix BioPharma (TSX:HBP)
過去 株価チャート
から 6 2023 まで 6 2024 Helix BioPharmaのチャートをもっと見るにはこちらをクリック